These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9208999)

  • 1. Resistance to activated protein C in unselected patients with arterial and venous thrombosis.
    Faioni EM; Razzari C; Martinelli I; Panzeri D; Franchi F; Mannucci PM
    Am J Hematol; 1997 Jun; 55(2):59-64. PubMed ID: 9208999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to activated protein C, highly prevalent amongst users of oral contraceptives with venous thromboembolism.
    Bennet L; Odeberg H
    J Intern Med; 1998 Jul; 244(1):27-32. PubMed ID: 9698021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inherited resistance to activated protein C caused by presence of the FV:Q506 allele as a basis of venous thrombosis.
    Dahlbäck B; Zöller B; Hillarp A
    Haemostasis; 1996 Oct; 26 Suppl 4():301-14. PubMed ID: 8979136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia.
    De Stefano V; Leone G
    Haematologica; 1995; 80(4):344-56. PubMed ID: 7590506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to activated protein C in healthy women taking oral contraceptives.
    Olivieri O; Friso S; Manzato F; Guella A; Bernardi F; Lunghi B; Girelli D; Azzini M; Brocco G; Russo C
    Br J Haematol; 1995 Oct; 91(2):465-70. PubMed ID: 8547095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombotic risk factors and oral contraception.
    Bokarewa MI; Falk G; Sten-Linder M; Egberg N; Blombäck M; Bremme K
    J Lab Clin Med; 1995 Sep; 126(3):294-8. PubMed ID: 7665978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombotic tendency in 75 symptomatic, unrelated patients with APC resistance.
    Melichart M; Kyrle PA; Eichinger S; Rintelen C; Mannhalter C; Pabinger I
    Wien Klin Wochenschr; 1996; 108(19):607-10. PubMed ID: 8921576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB; Sturk A
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to activated protein C (APC): mutation at Arg506 of coagulation factor V and vascular access thrombosis in haemodialysis patients.
    Födinger M; Mannhalter C; Pabinger I; Koizar D; Rintelen C; Hörl WH; Sunder-Plassmann G
    Nephrol Dial Transplant; 1996 Apr; 11(4):668-72. PubMed ID: 8671856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of hereditary thrombophilia for risk of thrombosis with oral contraceptives].
    Bauersachs R; Lindhoff-Last E; Ehrly AM; Kuhl H
    Zentralbl Gynakol; 1996; 118(5):262-70. PubMed ID: 8701622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor V gene mutation is a risk factor for cerebral venous thrombosis.
    Martinelli I; Landi G; Merati G; Cella R; Tosetto A; Mannucci PM
    Thromb Haemost; 1996 Mar; 75(3):393-4. PubMed ID: 8701395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor V gene mutation causing inherited resistance to activated protein C as a basis for venous thromboembolism.
    Dahlbäck B
    J Intern Med; 1995 Mar; 237(3):221-7. PubMed ID: 7891043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hypercoagulable states.
    Schafer AI
    Ann Intern Med; 1985 Jun; 102(6):814-28. PubMed ID: 3158262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prothrombin G20210A mutation and oral contraceptive use increase upper-extremity deep vein thrombotic risk.
    Vayá A; Mira Y; Mateo J; Falco C; Villa P; Estelles A; Corella D; Fontcuberta J; Aznar J
    Thromb Haemost; 2003 Mar; 89(3):452-7. PubMed ID: 12624627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective.
    Price DT; Ridker PM
    Ann Intern Med; 1997 Nov; 127(10):895-903. PubMed ID: 9382368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homozygous APC-resistance combined with inherited type I protein S deficiency in a young boy with severe thrombotic disease.
    Zöller B; He X; Dahlbäck B
    Thromb Haemost; 1995 May; 73(5):743-5. PubMed ID: 7482396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of oral contraceptives on hemostasis and thrombosis.
    Rosing J; Tans G
    Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S375-82. PubMed ID: 10368524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Activated protein C resistance: role in venous and arterial thrombosis].
    Emmerich J; Alhenc-Gelas M; Aiach M; Fiessinger JN
    Arch Mal Coeur Vaiss; 1996 Jun; 89(6):741-5. PubMed ID: 8760661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis.
    Deschiens MA; Conard J; Horellou MH; Ameri A; Preter M; Chedru F; Samama MM; Bousser MG
    Stroke; 1996 Oct; 27(10):1724-30. PubMed ID: 8841318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to activated protein C as a basis for venous thrombosis.
    Svensson PJ; Dahlbäck B
    N Engl J Med; 1994 Feb; 330(8):517-22. PubMed ID: 8302317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.